Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The corticotropin-releasing factor system is a central regulatory network for the physiological response to stress, primarily involving the peptide hormone corticotropin-releasing factor/hormone (CRF/CRH), its high-affinity receptors (CRF1R and CRF2R, both G protein-coupled receptors), related peptides (urocortins), and their binding proteins. Upon stress, CRF is released mainly from hypothalamic neurons and acts on the pituitary to stimulate the release of ACTH, leading to adrenal glucocorticoid production, which coordinates energy mobilization and suppresses non-essential functions. The CRF system also operates in peripheral tissues and throughout the central nervous system, mediating behavioral, autonomic, metabolic, and immune responses, and is implicated in a broad range of diseases including neuropsychiatric, inflammatory, and neurodegenerative disorders.
Receptor agonism (CRF/CRH and related peptides activate CRF1R and CRF2R); Receptor antagonism (CRF receptor antagonists block downstream stress hormone release and signaling)
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Corticotropin-releasing factor system (CRF system).